EyePoint (EYPT) Net Margin Growth (1y) (2011 - 2026)

EyePoint (EYPT) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 -1.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.71 Mn
Dec 31, 2025 -1.05 Mn
Sep 30, 2025 -590,445.00
Jun 30, 2025 -78,904.00
Mar 31, 2025 62,517.00
Dec 31, 2024 -24,084.00
Sep 30, 2024 -11,562.00
Jun 30, 2024 5,943.00
Mar 31, 2024 -54,915.00
Dec 31, 2023 30,495.00
Sep 30, 2023 74,030.00
Jun 30, 2023 40,947.00
Mar 31, 2023 -8,022.00
Dec 31, 2022 -24,878.00
Sep 30, 2022 -71,932.00
Jun 30, 2022 -65,709.00
Mar 31, 2022 -4,244.00
Dec 31, 2021 5,296.00
Sep 30, 2021 -16,017.00
Jun 30, 2021 17,728.00